Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 21/09/2012 → 25/07/2013 |
Collaborative partners
- King's College London
- Unknown (lead)
Funding
- Amgen Inc.: £117,843.00
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 747 on Negative Symptoms in Subjects with Schizophrenia.
- Patel, Maxine (Primary Investigator)
Project: Research